ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells (Q43938023)
Jump to navigation
Jump to search
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells |
scientific article published in March 2002 |
Statements
1 reference
ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells (English)
1 reference
1 reference
1 reference
1 reference
Rosa Caputo
1 reference
Gaetano Borriello
1 reference
Gabriella Zupi
1 reference
A Raffaele Bianco
1 reference
1 March 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference